CTRI/2024/07/069868尚未招募2 期
Open label randomised controlled trial of Telmisartan in Raynauds phenomenon associated with Systemic Lupus Erythematosus and Rheumatoid Arthritis - NI
Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 2210050 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age greater than or equal to 18 years.
- •2. Patients diagnosed as Systemic Lupus Erythematosus and Rheumatoid Arthritis
- •with history of Raynaud’s Phenomenon.
- •3. Willing to give signed written consent.
排除标准
- •1.Any co-existing significant/incapacitating chronic illness
- •2.Patient with symptomatic CAD
- •3.Patients on oral or sublingual nitrates
- •4.Patient who are pregnant or reproductive couples who have intention of pregnancy
- •5.Patients with known contraindication to either of IPs or SOC
研究者
相似试验
尚未招募
2 期
To see if Telmisartan helps to improve the symtoms of Raynauds Phenomena (discoloration/pain in fingers on exposure to cold temperatures) in patients of Systemic sclerosis or MCTDCTRI/2024/07/069866Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 221005
尚未招募
4 期
Randomized clinical trial on efficacy of telmisartan compared to vitamin E on histopathological improvement in patients with nonalcoholic steatohepatitis.onalcoholic steatohepatitis (NASH)SLCTR/2016/013Bangabandhu Sheikh Mujib Medical University
已完成
不适用
Randomized, open-label, phase 3 study of Temsirolimus Intravenous (CCI-779) at two dose levels compared to the treatment of choice of the Investigator in patients with relapsed and refractory mantle cell lymphoma (LCM)Mantle cell lymphoma-C831 Mantle cell lymphomaC831PER-005-06ABORATORIOS WYETH S.A.,
已完成
不适用
Open label, randomized controlled trial of Pemafibrate to evaluate renopotective effect in CKD patientschronic renal failure, dyslipidemiaJPRN-UMIN000042284kyushu university140
进行中（未招募）
不适用
Does having regular follow-up after surgery lead to early detection of the cancer returning, resulting in improved survival and better quality of life in patients who have had gullet or gastric cancer removal?Oesophageal or gastric cancerCancerISRCTN14417629niversity of Oxford952